1104
J. H. M. Lange et al. / Tetrahedron Letters 43 (2002) 1101–1104
(29), 91 (100); HRMS (EI): calcd for C18H20N2O (M+ free
base) 280.1576; found 280.1579.
17. Groves, J. T.; Chambers, R. R. J. Am. Chem. Soc. 1984,
106, 630–638.
24. Analytical data for 3-allyl-4-benzyl-1-phenylpiperazin-2-
18. Analytical data for 4-benzyl-1-phenylpiperazin-2,5-dione
7: mp 157–158°C; 1H NMR (200 MHz, CDCl3): l 4.04 (s,
2H), 4.42 (s, 2H), 4.66 (s, 2H), 7.23–7.48 (m, 10H); 13C
NMR (100 MHz, DMSO-d6): l 48.8, 50.5, 53.0, 126.1,
127.4, 128.2, 128.7, 129.3, 129.5, 136.8, 141.0, 164.6,
164.7; MS (ESI+): (MH)+ m/z 281; MS (EI): m/z (rel.
intensity) 280 (72), (189 (5), 161 (29), 105 (35), 104 (39),
91 (100); HRMS (EI): calcd for C17H16N2O2 (M+)
280.1212; found 280.1213.
1
one 10b: mp 118–119°C; H NMR (200 MHz, CDCl3): l
2.50–2.81 (m, 2H), 2.85–3.08 (m, 2H), 3.32–3.53 (m, 3H),
3.65–3.81 (m, 1H), 4.10 (d, J=13 Hz, 1H), 5.08–5.26 (m,
2H), 5.91–6.14 (m, 1H), 7.18–7.43 (m, 10H); 13C NMR
(100 MHz, DMSO-d6): 35.0, 46.7, 49.1, 58.1, 65.2, 117.3,
126.5, 126.9, 127.8, 128.9, 129.4, 129.5, 135.9, 138.8,
143.4, 169.0; MS (ESI+): (MH)+ m/z 307; MS (EI): m/z
(rel. intensity) 265 (30), 91 (100); HRMS (EI): calcd for
C17H17N2O
265.1355.
(M+−CH2CHꢀCH2)
265.1341;
found
19. Uchida, H.; Ohta, M. Bull. Chem. Soc. Jpn. 1973, 46,
3612–3613.
25. Analytical data for 3,4-dibenzyl-1-phenylpiperazin-2-one
10c: mp 109–111°C; 1H NMR (200 MHz, CDCl3): l
2.50–2.63 (m, 1H), 2.93–3.05 (m, 1H), 3.15–3.42 (m, 4H),
3.49 (d, J=13 Hz, 1H), 3.59–3.65 (m, 1H), 4.15 (d, J=13
Hz, 1H), 6.98–7.07 (m, 2H), 7.17–7.40 (m, 13H); 13C
NMR (100 MHz, DMSO-d6): 36.7, 46.2, 48.7, 58.3, 66.5,
126.5, 126.7, 127.0, 127.7, 128.4, 128.9, 129.4, 129.5,
130.5, 138.6, 139.4, 143.3, 169.1; MS (ESI+): (MH)+ m/z
357; MS (EI): m/z (rel. intensity) 265 (34), 91 (100);
HRMS (EI): calcd for C17H17N2O (M+−CH2C6H5)
265.1341; found 265.1352. Synthesis of 3,4-dibenzyl-1-
phenylpiperazin-2-one 10c: 4-Benzyl-1-phenylpiperazin-2-
one (3.50 g, 13.2 mmol) was dissolved in a mixture of dry
THF (35 mL) and DMPU (17.5 mL) under a nitrogen
atmosphere. The resulting solution was cooled to −78°C
and LDA (6.59 mL, 2 M solution in THF, 13.2 mmol)
was added. After stirring for 35 min benzyl bromide (1.8
mL, 15.2 mmol) was added and the resulting solution was
allowed to attain room temperature and stirred
overnight. A solution of NaHCO3 (5% aq., 175 mL) and
diethyl ether were added. The organic layer was twice
washed with water, dried over MgSO4, filtered and con-
centrated in vacuo. The resulting oil was crystallised from
diethyl ether to furnish 3,4-dibenzyl-1-phenylpiperazin-2-
one (3.53 g, 75% yield) as a white solid.
20. Analytical data for 4-benzyl-1-phenylpiperazin-2-one 9a:
mp 104–105°C; 1H NMR (200 MHz, CDCl3): l 2.76–2.85
(m, 2H), 3.34 (s, 2H), 3.62 (s, 2H), 3.63–3.72 (m, 2H),
7.20–7.45 (m, 10H); MS (ESI+): (MH)+ m/z 267.
21. Bruderer, H.; Kierstead, R. W.; Mullin, J. G.; Naka-
mura, K.; O’Brien, J. P.; Tateishi, M.; Teitel, S. Eur.
Patent 0126480, 1984; Chem. Abstr. 1984, 102, 132070.
22. Analytical data for 4-benzyl-1-(2-methoxyphenyl)-
piperazin-2-one 9b: mp 113–114°C (lit.20 mp 109–111°C);
1H NMR (200 MHz, CDCl3): l 2.80 (t, J=6 Hz, 2H),
3.34 (s, 2H), 3.52–3.62 (m, 2H), 3.64 (s, 2H), 3.83 (s, 3H),
6.93–7.02 (m, 2H), 7.16–7.40 (m, 7H); 13C NMR (100
MHz, DMSO-d6): l 49.6, 56.3, 57.8, 61.3, 113.1, 121.3,
127.9, 129.0, 129.5, 129.7, 129.8, 131.1, 137.9, 155.4,
166.5; MS (ESI+): (MH)+ m/z 297; MS (EI): m/z (rel.
intensity) 296 (28), 267 (80), 205 (91), 91 (100); HRMS
(EI): calcd for C18H20N2O2 (M+) 296.1525; found
296.1533.
23. Analytical data for 4-benzyl-3-methyl-1-phenylpiperazin-
1
2-one hydrochloride 10a: mp 206–207°C; H NMR (200
MHz, CDCl3): l 1.56 (d, J=7 Hz, 3H), 2.55–2.68 (m,
1H), 2.96–3.10 (m, 1H), 3.33–3.75 (m, 4H), 4.00 (d, J=13
Hz, 1H), 7.20–7.53 (m, 10H); MS (ESI+): (MH)+ m/z
281; MS (EI): m/z (rel. intensity) 280 (4), 237 (65), 189